Bryan
Jones, PhD
Chief Executive Officer
30+ years in biotech leadership and drug development, including biologics, small molecules and drug device programs. Deep expertise in clinical strategy and business development and growing startup organizations.
Dane
Callow
Chief Financial Officer
Life sciences finance and operations leader with nearly two decades of experience stepping into high-impact leadership roles for organizations ranging from venture-backed startups to publicly traded companies.
Dvorit Samid, PhD
Chief Scientific Advisor
Former Differentiation Therapy Section Chief at NCI and subsequently nearly 3 decades of pharmaceutical/biotech leadership, playing a key role in drug development, strategic alliances and commercialization.
Charles
Ellis, MD
Director of clinical research
Clinical research leader and physician-scientist with 40+ years of experience, including leadership of 250+ clinical studies and pioneering research in psoriasis, atopic dermatitis and other dermatologic conditions.
Experienced Management Team
Demonstrated success in advancing drug development programs, regulatory approval and commercialization